论文部分内容阅读
目的:探讨分析四逆散合半夏泻心汤联合西药治疗肝胃不和型慢性胃炎的临床疗效。方法:将120例肝胃不和型慢性胃炎患者纳入研究并随机分组,观察组与对照组各60例,对照组给予单纯西药治疗,根据患者个体情况予奥美拉唑肠溶片、莫沙必利、胃三联药物口服;观察组在对照组基础上给予四逆散合半夏泻心汤治疗。治疗30天,并于治疗结束1个月后进行随访,比较两组患者临床疗效差异,观察不良反应发生情况。结果:观察组患者临床治疗总有效率为93.33%,显著高于对照组的80.00%,差异具有统计学意义(P<0.05);观察组患者治疗后的中医证候积分为(4.23±1.37)分,复发率为5.00%,均低于对照组,差异具有统计学意义(P<0.05)。结论:四逆散合半夏泻心汤联合西药治疗肝胃不和型慢性胃炎临床效果显著,复发率较低,值得临床推广使用。
Objective: To investigate the clinical efficacy of Siniosan Banxiaxiexin Decoction combined with western medicine in the treatment of chronic gastritis with hepatomegaly and non-type. Methods: A total of 120 patients with chronic gastritis with hepatomegaly and gastric disorganization were enrolled in the study and randomly divided into observation group and control group with 60 patients in each group. The control group was given western medicine alone. According to the patient’s condition, omeprazole enteric-coated tablets, Weili, stomach triple oral; observation group was given on the basis of the control group Sini San Banxiaxiexin Tang treatment. After 30 days of treatment, the patients were followed up 1 month after the end of treatment. The difference of clinical efficacy between the two groups was compared and the incidence of adverse reactions was observed. Results: The total effective rate of clinical observation in the observation group was 93.33%, which was significantly higher than that in the control group (80.00%), the difference was statistically significant (P <0.05); the TCM syndrome score in the observation group was (4.23 ± 1.37) Points, the recurrence rate was 5.00%, lower than the control group, the difference was statistically significant (P <0.05). Conclusion: Sini Powder Banxiaxiexin Decoction combined with Western medicine in the treatment of chronic gastritis with liver-stomach incompetence has a significant clinical effect and a low recurrence rate, which is worthy of clinical promotion and use.